Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial
AstraZeneca
Richard T Penson; Ricardo Villalobos Valencia; David Cibula; Nicoletta Colombo; Charles A Leath; Mariusz Bidziński; Jae-Weon Kim; Joo Hyun Nam; Radoslaw Madry; Carlos Hernández; Paulo A R Mora; Sang Young Ryu; Tsveta Milenkova; Elizabeth S Lowe; Laura Barker; Giovanni Scambia